National Health Investors (NYSE:NHI) Updates FY24 Earnings Guidance

National Health Investors (NYSE:NHI) issued an update on its FY24 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $4.43-$4.44 for the period, compared to the consensus estimate of $4.52. National Health Investors also updated its FY 2024 guidance to 4.430-4.440 EPS.

Wall Street Analyst Weigh In

Several research firms have commented on NHI. Truist Financial lifted their target price on shares of National Health Investors from $65.00 to $78.00 and gave the stock a “hold” rating in a research report on Friday, August 30th. StockNews.com downgraded National Health Investors from a “buy” rating to a “hold” rating in a research report on Tuesday, October 15th. Wells Fargo & Company downgraded shares of National Health Investors from an “overweight” rating to an “equal weight” rating and lifted their price target for the stock from $81.00 to $86.00 in a research note on Tuesday, October 1st. Finally, Bank of America began coverage on shares of National Health Investors in a research report on Tuesday, September 24th. They issued a “buy” rating and a $92.00 price objective on the stock. Four equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat.com, National Health Investors has an average rating of “Moderate Buy” and a consensus target price of $73.29.

National Health Investors Stock Performance

Shares of NHI traded up $2.88 during trading hours on Thursday, reaching $79.64. 451,067 shares of the company traded hands, compared to its average volume of 194,790. The business has a fifty day moving average price of $80.37 and a 200-day moving average price of $73.21. The company has a quick ratio of 10.27, a current ratio of 10.27 and a debt-to-equity ratio of 0.91. The stock has a market capitalization of $3.46 billion, a P/E ratio of 27.09, a P/E/G ratio of 5.05 and a beta of 1.05. National Health Investors has a 12-month low of $49.25 and a 12-month high of $86.13.

National Health Investors (NYSE:NHI) last posted its earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.07 by ($0.42). The firm had revenue of $63.32 million for the quarter, compared to analysts’ expectations of $67.93 million. National Health Investors had a return on equity of 10.11% and a net margin of 39.11%. The company’s revenue was up 1.7% compared to the same quarter last year. During the same period in the previous year, the company earned $1.08 earnings per share. Equities analysts anticipate that National Health Investors will post 4.48 EPS for the current fiscal year.

National Health Investors Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 29th. Investors of record on Tuesday, December 31st will be issued a $0.90 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $3.60 annualized dividend and a yield of 4.52%. National Health Investors’s dividend payout ratio (DPR) is presently 122.45%.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.